Semaglutide, a glucagon-like peptide 1 (GLP-1) agonist, significantly improved maximal walking distance in people with ...

Injectable semaglutide has better bioavailability, researchers say, but the many patients who want an oral drug are an unmet ...

Novo Nordisk (NVO) announced on Saturday that a late-stage trial for its popular weight loss therapy Ozempic in adults with ...

Comedian Nikki Glaser is a big supporter of anyone taking Ozempic. The 40-year-old comedian appeared on the March 24 episode ...

Semaglutide, the diabetes and weight loss drug that’s commonly known as Ozempic, can help patients of peripheral artery ...

Gabby Thomas is sharing the hilariously relatable reason she’s not a fan of Ozempic. On March 21, the 28-year-old track star, ...

Serious adverse events were reported in 74 participants in the semaglutide arm and 78 participants in the placebo arm, and SAEs that were possibly/probably treatment-related occurred in 5 and 6 ...

For example, a 5/1 ARM will have the same rate for the first five years, then can adjust each year after that—meaning the rate might go up or down, based on the market. An ARM isn’t for everyone.

stroke and CV death in those treated with oral semaglutide vs placebo. The proven cardiovascular benefit reflects a profound clinical impact for our patients who now have an oral option to improve ...

Successful initial administration and full enrollment in first-in-human LIBERATE-1 ™ study of NPM-115 (exenatide implant) in obese and ...

Ozempic should be injected subcutaneously in the abdomen, thigh, or upper arm. It is important to follow ... Clinical trials, including the STEP (Semaglutide Treatment Effect in People with ...